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Antibodies to Burkholderia pseudomallei were detected 
in 16% of children in Siem Reap, Cambodia. This organism 
was isolated from 30% of rice paddies in the surrounding 
vicinity. Despite the lack of reported indigenous cases, meli-
oidosis is likely to occur in Cambodia.
B
urkholderia pseudomallei is a soil saprophyte and the 
cause of melioidosis (1). This bacterium can be isolated 
from soil and water in melioidosis-endemic regions of the 
tropics, where infection is acquired after bacterial inocula-
tion, inhalation, or ingestion (1). Most reported cases occur 
in Thailand and northern Australia, but this statistic likely 
represents a fraction of the true extent of disease because 
microbial culture, the mainstay of diagnostic conﬁ  rmation, 
is not available across much of rural Asia. The largest con-
centration of conﬁ  rmed melioidosis cases worldwide oc-
curs in northeast Thailand, where the disease accounts for 
20% of all community-acquired septicemias (2). The death 
rate for affected adults in this setting is ≈50% (2). Northeast 
Thailand is bordered by Lao People’s Democratic Republic 
(PDR) to the east and southeast and Cambodia to the south. 
Melioidosis has recently been recognized in Lao PDR af-
ter a diagnostic microbiology laboratory was instituted at 
Mahosot Hospital, Vientiene (3), and B. pseudomallei has 
been isolated from the surrounding environment (4). By 
contrast, there are no reports in the literature of indigenous 
melioidosis or environmental isolation of B. pseudomallei 
in adjacent Cambodia. Two cases of melioidosis have been 
reported in Cambodian residents in Canada and the United 
States, respectively; both persons had spent several years 
in refugee camps in Thailand (5,6). We propose that meli-
oidosis occurs in Cambodia but is unrecognized because of 
the lack of diagnostic microbiology facilities. The aims of 
this study were to conduct a seroprevalence study of chil-
dren living in Siem Reap, Cambodia, to detect the presence 
of antibodies resulting from exposure to B. pseudomallei, 
and to determine whether this organism could be isolated 
from their environment.
The Study
A prospective, cross-sectional study was conducted at 
Angkor Hospital for Children, Siem Reap, from December 
2005 through April 2006. Unselected consecutive serum 
samples were collected from children between birth and 16 
years of age from the biochemistry and hematology labora-
tory of Angkor Hospital for Children, Siem Reap. Blood 
samples were collected from outpatients and inpatients. 
These blood tests were ordered by the primary physician 
for other reasons, and the sample used represented surplus 
material. Samples were centrifuged at 3,000 rpm for 10 
min and the serum stored at –30°C. Target sample numbers 
were 40–60 per year group. An anonymous database was 
created to record sex, age, and indirect hemagglutination 
assay (IHA) titer. The presence and titer of antibodies to B. 
pseudomallei were determined by using the IHA, as pre-
viously described (7), with the exception that the pooled 
antigens used were from 2 B. pseudomallei isolates (strains 
001a and 002a) isolated 10 years ago in Phnom Penh, Cam-
bodia. These patients’ isolates were sent to us for identiﬁ  -
cation in 1996, although the details of their clinical prov-
enance are unknown. Although data on these isolates are 
unpublished, their existence suggests the presence of meli-
oidosis in Cambodia. Serum samples were tested in random 
order. Any detectable IHA titer was interpreted as evidence 
of exposure to B. pseudomallei. Ethical approval for this 
study was obtained from the Faculty of Tropical Medicine, 
Mahidol University, Thailand, and the Institutional Review 
Board Committee of the Angkor Hospital for Children.
Environmental sampling was performed during a 1-day 
period in January 2006. Four soil samples were collected 
from each of 10 different paddy ﬁ  elds around Siem Reap. 
Samples were collected on minor roads leading from route 
6 (Thailand to Phnom Penh) up to 80 km southeast and 
40 km northwest of Siem Reap. Sampling was performed 
and B. pseudomallei recovered as previously described (8). 
Susceptibility testing was performed by disk diffusion as-
say for ceftazidime, imipenem, and doxycycline, and by E 
test for trimethoprim-sulfamethoxazole. Interpretive stan-
dards were based on guidelines from the Clinical and Lab-
oratory Standards Institute (formerly National Committee 
for Clinical Laboratory Standards).
Serum samples were obtained from 968 children, of 
whom 528 (54.5%) were male. The number of samples 
collected per year group is shown in the Figure. Fewer 
serum samples were collected from children 15 and 16 
years of age because only a small number of samples were 
available from these age groups. A total of 159 children 
(16.4%) had a detectable IHA titer; values ranged from 10 
to 10,240 (median 10, interquartile range [IQR] 20–640). 
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males (86/440 females [19.5%] vs. 73/528 males [13.8%], 
p = 0.02), but the distribution of titer values in the popula-
tion of positive female children was not signiﬁ  cantly dif-
ferent from that in the population of positive male children. 
The proportion of children with any detectable IHA titer 
rose with age (Figure). An IHA titer >160 is used in some 
centers in Thailand to support a diagnosis of melioidosis in 
patients with clinical features consistent with this diagno-
sis. Sixty-three children (6.5%) had an IHA titer >160.
B. pseudomallei was isolated from 12 (30%) of 40 
soil samples taken in 6 (60%) of 10 rice ﬁ  elds; 1 rice ﬁ  eld 
was positive for all 4 samples, 3 ﬁ  elds were positive for 2 
samples, and 2 ﬁ  elds were positive for 1 sample. CFU of 
B. pseudomallei per gram of soil ranged from 1 to 5,000 
(median 90 CFU/g, IQR 20–250 CFU/g). B. thailandensis, 
a highly related but usually nonpathogenic organism, was 
isolated from 1 sample at a concentration of 5,000 CFU/g 
of soil. All 12 B. pseudomallei isolates were susceptible to 
ceftazidime, imipenem, amoxicillin-clavulanate, chloram-
phenicol, doxycycline, and co-trimoxazole.
Conclusions
Detection of B. pseudomallei antibodies in 16% of 
Cambodian children is consistent with environmental ex-
posure to this pathogen. The proportion of children with 
detectable antibodies is lower than that of children in ad-
jacent northeast Thailand (10), although the overrepresen-
tation of children in the ﬁ  rst 3 years of life in this study 
could result in a lower comparative ﬁ  gure. The residents 
of both regions are predominantly agricultural workers 
and their families, and it seems unlikely that Cambodian 
children would have a lower level of environmental ex-
posure. The median B. pseudomallei colony count of 90 
CFU/g soil was lower compared with a reported ﬁ  gure of 
230 CFU/g soil in northeast Thailand (8), which suggests 
that the bacterial inoculum present during a given expo-
sure may be lower in Cambodia than Thailand. However, 
a direct link between environmental bacterial biomass and 
the rate of seropositivity in the healthy population remains 
unproven. Seropositivity using IHA is a crude surrogate for 
good blood culture–supported clinical epidemiology and 
case detection, although it provides a strong indirect indi-
cation of the presence of human melioidosis as a clinically 
important disease in Cambodia. It also underlines the need 
for building diagnostic microbiology capacity across rural 
Southeast Asia.
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Figure. Indirect hemagglutination assay (IHA) titer for 968 children 
living in Siem Reap, Cambodia. None of the children was known to 
have melioidosis. The number of children by age group follows: <1 
y, 106 children; 1 y, 98 children; 2 y, 93 children; 3 y, 54 children; 4 
y, 50 children; 5 y, 62 children; 6 y, 55 children; 7 y, 57 children; 8 y, 
44 children; 9 y, 49 children; 10 y, 50 children; 11 y, 41 children; 12 
y, 49 children; 13 y, 66 children; 14 y, 54 children; 15 y, 23 children; 
16 y, 17 children.Burkholderia pseudomallei, Cambodia 
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